Developer of genetically engineered salmon eyes Canadian regulators
Sarah Schmidt
August 27, 2010
Montreal Gazette
The developer of genetically engineered salmon for human consumption is now setting its sights on Health Canada, after U.S. regulators on Thursday announced their review of AquaBounty Technologies Inc.’s historic application for the American market is nearly complete.
The U.S. Food and Drug Administration published details of the last stages of its review for AquAdvantage Salmon, made from eggs produced in a hatchery in Prince Edward Island. The genetically engineered fish can grow at twice the normal rate, and the company, headquartered in Massachusetts with Canadian operations in P.E.I. and Newfoundland and Labrador, has been trying for a decade to get approval to become the first genetically engineered animal that people would eat.
Read the full story in The Montreal Gazette
Related stories:
- CBC News; August 31, 2010; "Verdict on genetically modified salmon pending"
Posted August 27th, 2010
